Cowen Group

Cowen Group

Cowen Group

FinSMEs

Orchard Therapeutics Prices Initial Public Offering

Stock markets Health Costs
$200,000,000 IPO
PE Hub , FinSMEs

VC-backed Orchard Therapeutics goes public

Stock markets
TechCrunch

Livongo Health expands under new offering with Abbott Labs

Health Cloud
$150,000,000 Venture capital (Series C)
FinSMEs

Orchard Therapeutics Raises $150M in Series C Financing

Funding Health
$75,000,000 IPO
PE Hub

VC-backed Kezar Life Sciences unveils IPO

Stock markets Health
Acquisition
Xconomy

Livongo Health Grows with Purchase of Weight Loss Startup Retrofit

Health
$105,000,000 Venture capital (Series E)
MedCity News , Forbes , Xconomy

Livongo rakes in $105M, introduces partnership with Cambia Health Solutions

GeekWire , FinSMEs

Cambia Health and Livongo partner to bring personal, tech-driven diabetes program to Pacific Northwest

Health Funding
$110,000,000 Venture capital (Series B)
PE Hub

| Gene therapy developer Orchard Therapeutics raises $110 million: Reuters

Health Funding
Xconomy

MyoKardia Heart Drug Boosts Blood Flow, Sends Shares Soaring

Health
Private equity
Reuters

CEFC China to buy 20 percent stake in U.S. brokerage Cowen

Venture capital
FinSMEs

Semma Therapeutics Raises Additional Funding

$52,500,000 Venture capital (Series D)
TechCrunch , VentureBeat , e27

Smart diabetes management service Livongo Health raises $52.5M and looks to new markets

Health People
PE Hub

Livongo Health rakes in $52.5 mln

Funding Messaging Data leaks
$20,000,000 Grant
FierceBiotech

Orchard gets $20M to trial ‘bubble boy’ gene therapy

$5,000,000 Grant
FinSMEs , businesswire

Semma Therapeutics Receives $5M Grant from California Institute of Regenerative Medicine

£21,000,000 Venture capital (Series A)
b3cnewswire

Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies

$44,500,000 Venture capital (Series C)
FinSMEs

Livongo Health Completes $44.5M Series C Financing

Health Funding
Xconomy

Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations

Health Stock markets
Xconomy

Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO

Health Funding